Andere talen Zai Lab Limited

Aandelen

ZLAB

US98887Q1040

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
15,91 ^USD	+1,08%		+13,08%	-41,79%

17/04	Aziatische aandelen verhandeld in de VS als American Depositary Receipts blijven vlak in de handel van woensdag	MT
11/04	CEO van Zai Lab en anderen "verwachten" geen verkoop van bedrijfsaandelen in de rest van 2024	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading	17/04
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024	15/04
Zai Lab Statement on Executive Management Team's Agreement on Share Activities	12/04
Zai Lab CEO, Others 'Do Not Anticipate' Selling Company Shares in Remainder of 2024	11/04
Zai Lab Statement on Executive Management Team’s Agreement on Share Activities	11/04
Zai Lab Changes Record Date	11/04
Zai Lab Grants Share Options, Restricted Share Units to Eligible Personnel	05/04
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI Meets Primary Endpoint	02/04
Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs	02/04
Bristol-Myers Squibb Therapy for Pretreated Non-Small Cell Lung Cancer Meets Primary Endpoint	01/04
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...	01/04
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases	28/03
Zai Lab Reports Lesser Loss in 2023	28/03
Zai Lab, Novocure Say TTFields Therapy Delays Intracranial Progression in Non-Small Cell Lung Cancer Brain Metastases Patients	27/03
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer	27/03
Zai Lab Partner Novocure Announces Metis Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating A Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer	27/03
Asian Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading	20/03
Asian Equities Traded in the US as American Depositary Receipts End Week Lower in Friday Trading	15/03
Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors	14/03
Zai Lab Limited to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate for Treatment of Solid Tumors	14/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zai Lab Limited

Aandelen

ZLAB

US98887Q1040

Andere talen

Filters